RecruitingNot applicableNCT05243082

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

Studying Neuroendocrine neoplasm of pancreas

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oslo University Hospital
Intervention
Radio frequency ablation(device)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2029

Study locations (1)

Collaborators

Haukeland University Hospital · St. Olavs Hospital · University Hospital of North Norway

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05243082 on ClinicalTrials.gov

Other trials for Neuroendocrine neoplasm of pancreas

Additional recruiting or active studies for the same condition.

See all trials for Neuroendocrine neoplasm of pancreas →

← Back to all trials